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Abstract 
Escherichia coli expressing the K1 capsule are a major cause of sepsis and meningitis in 
human neonates. The development of these diseases is dependent on the expression of a 
range of virulence factors, many of which remain uncharacterised. Here, we show that all but 
one of 34 E. coli K1 neonatal isolates carry clbA and clbP, genes contained within the pks 
pathogenicity island and required for the synthesis of colibactin, a polyketide-peptide 
genotoxin that causes genomic instability in eukaryotic cells by induction of double-strand 
breaks in DNA. Inactivation of clbA and clbP in E. coli A192PP, a virulent strain of serotype 
O18:K1 that colonizes the gastrointestinal tract and translocates to the blood compartment 
with very high frequency in experimental infection of the neonatal rat, significantly reduced 
the capacity of A192PP to colonize the gut, engender double-strand breaks in DNA and 
cause invasive, lethal disease. Mutation of clbA, which encodes a pleiotropic enzyme also 
involved in siderophore synthesis, impacted virulence to a greater extent than mutation of 
clbP, encoding an enzyme specific to colibactin synthesis. Restoration of colibactin gene 
function by complementation re-established the fully virulent phenotype. We conclude that 
colibactin contributes to the capacity of E. coli K1 to colonise the neonatal gastrointestinal 
tract and to cause invasive disease in the susceptible neonate. 
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Introduction 
Escherichia coli isolates belonging to phylogenetic group B2 are found with increasing 
frequency in the feces of healthy individuals from high-income countries (1) and are 
responsible for a range of extraintestinal infections that include those of the urinary tract, 
sepsis, pneumonia and neonatal meningitis (2). These extraintestinal pathogenic E. coli 
(ExPEC) strains carry genes encoding a diverse range of virulence determinants that 
promote colonization, invasion, survival in the blood compartment and the capacity to evade 
host defences and damage the host (3). These virulence-enhancing genes tend to cluster on 
pathogenicity islands, genomic elements that facilitate dissemination by horizontal gene 
transfer (4). The pks genomic island is found in 30-40% of E. coli B2 strains and codes for 
the production of colibactin, a polyketide-peptide genotoxin of as-yet unknown chemical 
structure that causes double-strand (ds) breaks in DNA, leading to cell cycle arrest, 
chromosome instability and increased lymphopenia in septic rodents (5-8). Carriage of the 
pks island is linked to long-term persistence in the gastrointestinal (GI) tract (9) and pks –
bearing strains represent a high-virulence subset within the B2 group (6). The 54kb pks 
island encodes nonribosomal peptide synthases, polyketide synthases and hybrid 
synthases, in addition to accessory, tailoring and editing enzymes; the clbA gene encodes a 
phosphopantetheinyl transferase required for colibactin synthesis and clbP specifies a D-
amino peptidase involved in colibactin maturation (10, 11). The pks island also contributes to 
the synthesis of siderophores by virtue of the broad substrate specificity of ClbA, impacting 
iron acquisition and the ability to survive in the blood compartment (12). 
The pks island was initially identified in an E. coli isolate from a case of neonatal bacterial 
meningitis (NBM) (6). E. coli is a leading cause of NBM and neonatal sepsis (13-15); these 
life-threatening conditions arise following vertical transmission of the bacteria from mother to 
infant during or shortly after birth and the large majority express the anti-phagocytic 
polysialic acid K1 capsule (16). Data from human infections is sparse, but studies using rat 
models of infection indicate that E. coli K1 strains initially colonize the GI tract of the 
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neonatal rat and subsequently enter the blood circulation via the mesenteric lymphatic 
system, causing severe systemic infection with a high likelihood of central nervous system 
(CNS) involvement and local inflammation (17-21), much as in human infections. The 
neonatal rat model adopted for these studies replicates the strong age-dependency 
characteristic of the human condition; systemic infection appears to be related to the 
capacity of the colonizing bacteria to translocate across the immature GI tract of the 
newborn (18, 21). Neuropathogenic strains of E. coli K1 have arisen by clonal expansion 
(22) and although they are not generally responsible for systemic infection in post-neonatal 
infants and adults, constitute a group of highly virulent opportunistic pathogens for 
susceptible neonates. We therefore examined the extent of involvement of colibactin 
production in the pathogenesis of neonatal E. coli K1 systemic infection by determining the 
degree of pks carriage in clinical isolates and the impact of mutation of clbA and clbP in the 
course of infection in a rat model of neonatal infection. The data indicate that colibactin and 
siderophore synthesis has a substantial impact on GI tract colonization and the capacity of 
pks-positive E. coli K1 to cause invasive disease. 
METHODS 
Bacterial strains 
E. coli O18:K1 strain A192PP was derived from septicemia isolate E. coli A192 (22) by two 
rounds of passage through neonatal rat pups, with bacterial recovery from the blood (23). 
Thirty four isolates of E. coli K1 from neonatal blood, obtained between 2001 and 2014 at 
Great Ormond Street Hospital, London, were kindly provided by Professor Nigel Kline and 
Ms Elaine Cloutman-Green (Institute of Child Health, University College London). The 
presence of K1 capsule was confirmed with K1-specific bacteriophage K1E (24). Inactivation 
of E. coli A192PP genes was undertaken using bacteriophage λ Red recombinase as 
described (25). The mutants employed are shown in Table 1. For complementation, clbA 
was cloned into plasmid pASK75 (26), and clbP into plasmid pBRSK (10) (Table 1): 
clbA::kan and  clbP::kan alleles were amplified by PCR from chromosomal DNA of 
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SP15clbA::kan and SP15clbP::kan using primers clbA-F/clbA-R and clbP-F/clbP-R, 
respectively, and were used to transform strain A192PP (clbA-F: CAG ATA CAC AGA TAC 
CAT TCA; clbA-R: CTA GAT TAT CCG TGG CGA TTC; clbP-F: GTG AAC TGA 
GCG AAA TAT TGG CTA ATC; clbP-R: TTA CTC ATC GTC CCA CTC CTT GTT G). The 
allelic exchanges were confirmed by PCR. 
Identification of pks island 
Strains were screened by PCR for the presence of clbA and clbP genes representative of 
the pks island. PCR reactions were performed using HotStart Taq kit (QIAgen, Limburg, 
Netherlands) in 25 μl containing 1 pmol F and R primers, 1 x buffer, 1 x HotStart Taq Buffer 
Mix, 1 μl DNA and dH2O. Reactions were heated to 95
oC for 15 min, followed by 35 cycles at 
95oC for 30 s, 60oC for 30 s and 72oC for 90 s, followed by of one cycle of 72oC for 10 min. 
PCR products were detected following separation by electrophoresis using 1.5% agarose 
gels. 
 
 
 
Genome sequencing 
Bacteria were grown overnight in Mueller-Hinton broth at 37°C using an orbital incubator 
(200 orbits min). Genomic DNA was extracted from 1 ml of culture using QIAamp DNA mini 
kit (QIAgen). Sequencing library preparation was carried out with Illumina Nextera XT 
according to the manufacturer’s instructions. Mi-Seq sequencing (2 x 151 bp) was carried 
out following the manufacturer’s standard protocols (Illumina Inc, USA). Sequencing reads 
were quality controlled using Trimmomatic (26).  Nucleotide sequence of the A192PP 
genome has been deposited in the European Nucleotide Archive (http://www.ebi.ac.uk/ena/; 
accession number PRJEB9141). pks islands were identified in E. coli genomes by BLAST 
analysis of the pks element in IHE3034 (AM229678). pks islands and their insertion sites 
from nine E. coli genomes were compared using the Artemis Comparison Tool (27). Fastq 
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files for A192PP were mapped against the IHE3034 pks element using the Burrows-Wheeler 
Aligner software package (28).  
Colibactin production 
Colibactin induces senescence and consequent megalocytosis in cultured eukaryotic cells, 
manifest as progressive enlargement of the cell body and nucleus and the absence of 
mitosis. We quantified the extent of colibactin-induced megalocytosis using a methylene blue 
binding assay (12). E. coli strains were added to HeLa cells cultivated as described above at 
multiplicities of infection (MOIs) of between 12 and 400, co-cultured for 4 h and washed. 
Cells were then incubated for 72 h with cell culture medium containing 200 μg/ml gentamicin 
followed by staining with methylene blue. Dye binding was determined 
spectrophotometrically at OD660. 
 
Genotoxicity assay 
The capacity of colibactin to engender ds DNA breaks was determined in HeLa cells by γ-
H2AX immunofluorescence analysis (5, 29); this assay monitors the phosphorylation of 
histone H2AX, a sensitive marker of ds DNA breaks. HeLa cells (1.5 × 104 cells in 200 μl 
Dulbecco’s modified Eagle’s medium supplemented with 10% fetal calf serum, 80 µg/ml 
gentamicin and 0.1 unit/ml bovine insulin) were dispensed into 96-well cell culture plates. 
After incubation at 37oC in a 5% CO2 atmosphere for 24 h, the cells were washed and 
incubated with bacteria at MOIs of 20 to 100 bacteria per cell. After 5 h infection at 37oC in 
5% CO2, cells were washed 3 times with Hank’s Balanced Salts Solution and incubated at 
37oC in cell culture medium for 20 h with 200 μg/ml gentamicin. Cells were fixed in the plate 
with 4% paraformaldehyde and processed as previously described (12). Rabbit monoclonal 
anti-γ-H2AX antibody #9718 (Cell Signaling Technology Inc, Danvers MA) was diluted 1:500 
in blocking solution and incubated for 2 h at room temperature. IRDyeTM 800CW-
conjugated goat anti-rabbit secondary antibody was diluted 1:100 in blocking solution and 
incubated for 1 h. RedDot2 (Biotium) was used for DNA labelling. DNA and γ-H2AX were 
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visualized using an Odyssey Infrared Imaging Scanner (Li-Cor ScienceTec, Les Ulis, 
France) using 680 nm and 800 nm channels for RedDot2 and IRDyeTM800 respectively. 
Relative fluorescence units for γ-H2AX per cell (as determined by γ-H2AX divided by DNA 
content) were divided by vehicle controls to determine percentage change in 
phosphorylation of H2AX levels relative to control. All experiments were carried out in 
triplicate. 
 
 
 
Colonization and infection of neonatal rats 
Animal experiments were approved by the Ethical Committee of the UCL School of 
Pharmacy and the UK Home Office (HO) and were conducted under HO Project Licence 
PPL 80/2243. The procedure has been described in detail (30). Briefly, all members of a 
litter (12 pups) of two-day-old (P2) Wistar rat pups (Harlan UK) were fed 20 µl of mid-
logarithmic phase E. coli (2-6 X 106 CFU) from an Eppendorf micropipette. GI tract 
colonization was determined by culture of perianal swabs on MacConkey agar; bacteremia 
was detected by MacConkey agar culture of blood taken post mortem. Disease progression 
was determined by daily evaluation of symptoms of systemic infection (28). After sacrifice, 
samples from the proximal small intestine (SI), mid-SI, distal SI, colon, blood, mesenteric 
lymph nodes (MLN), liver, kidney and spleen were excised aseptically, transferred to ice-cold 
phosphate buffered saline (PBS) and homogenized. Bacteria were quantified by serial 
dilution culture on MacConkey agar and E. coli K1 confirmed with bacteriophage K1E.  
Immunohistochemical evaluation of tissue sections 
The entire GI tract was recovered immediately after culling of rat pups and 2 cm segments of 
the mid-SI removed as previously described (30). Tissues were placed in 10% formalin for 
24 h, embedded in paraffin and 5 μM sections cut. Dewaxed sections were subjected to 
antigen retrieval in 0.1 M trypsin for 6 min at 37°C, then in 10 mM sodium citrate buffer (pH 
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6.0) for 30 min at 94°C. After peroxidase blocking (DAKO S2023) for 5 min, sections were 
incubated with protein block reagent (2.5% normal goat serum) for 20 min and then with the 
monoclonal rabbit anti-γH2AX antibody #9718 (Cell Signaling Technology Inc, Danvers MA) 
at a dilution of 1:400 for 1 h. The slides were washed with Envision flex buffer (DAKO 
K8000) for 5 min, and then incubated with the polymer-peroxidase conjugate (DAKO, 
K4061) for 30 min. After a second wash, chromogenic development was performed for 5 min 
with 3,3′-diaminobenzidine (DAKO, K3468). The tissues were counterstained with 
haematoxylin. Histological images were transformed into digital microscopic images with the 
Pannoramic 250 Flash II scanning system (3DHISTECH, Budapest, Hungary). 
RESULTS 
The pks island is widely distributed amongst neonatal E. coli K1 isolates 
E. coli A192PP displays a high level of virulence in the rodent model of systemic infection 
(23); lethal infection in susceptible neonatal pups occurs following translocation across the 
small intestine, with evidence that the invading bacteria adopt a transcellular route across 
the epithelium (21). E. coli K1 virulence factors enabling colonization and invasion have not 
been elucidated in unambiguous fashion and we therefore examined A192PP for the 
presence of genes associated with the pks island; PCR indicated that the strain carried clbA 
and clbP. The presence of the pks island was confirmed by whole-genome sequencing of 
A192PP; the strain carries all genes required for colibactin production and the island 
contains no single nucleotide polymorphisms that distinguish it from the island found in 
O18:K1:H7 ExPEC strain IHE3034; similar observations were made with regard to the other 
sequences we interrogated. We then examined 34 E. coli K1 neonatal isolates for the 
presence of clbA and clbP; all but one isolate carried these two genes.  
Neonatal E. coli K1 isolates elicit genotoxic effects in vitro 
Seven neonatal E. coli K1 pks+ isolates were randomly selected and their capacity to elicit 
genotoxic effects in HeLa co-cultures was determined; in all cases, exposure of HeLa cells 
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to neonatal E. coli K1 isolates resulted in megalocytosis, a reliable marker of colibactin-
producing group B2 strains (Fig. 1) (31). E. coli A192PP also demonstrated the ability to 
induce megalocytosis in HeLa cell co-culture (Fig. 2B). 
Whilst disruption of clbA and clbP in E. coli A192PP did not affect growth kinetics in batch 
culture (Fig. 2A), induction of megalocytosis was not evident when HeLa cells were exposed 
to A192PPΔclbA::kan and A192PPΔclbP::kan derivatives of E. coli A192PP (Fig. 2B). 
Further, in contrast to the parent strain, A192PPΔclbA::kan and A192PPΔclbP::kan did not 
induce ds DNA breaks in HeLa cells (Fig. 2C). This functionality was restored when clbA and 
clbP were introduced on plasmid vectors (Fig. 2C), and the capacity of the complemented 
strains to induce γ-H2AX was comparable to the progenitor A192PP. 
Colibactin contributes to the virulence of E. coli K1 strain A192PP 
E. coli A192PP, ΔclbA::kan and ΔclbP::kan mutants and the complemented strains were 
examined for their capacity to induce lethal effects in a rat model of neonatal E. coli K1 
systemic infection. We have previously established that two-day-old (P2) rat pups are 
exquisitely susceptible to lethal infection following oral introduction of E. coli A192PP (23). 
Over a period of one week (P2-P9) the pups become progressively more resistant to 
infection, but not colonization, as a result of rapid maturation of the neonatal GI tract (21, 
32). In susceptible animals, E. coli A192PP cells begin to enter the blood circulation around 
24 h after GI tract colonization becomes apparent and within seven days all animals in an 
infected litter succumb to a highly disseminated infection. GI colonization of E. coli A192PP 
is stable in quantitative aspects over the period of investigation (21, 23). Here, P2 neonates 
became efficiently colonized in the GI tract by E. coli A192PP and all derivatives within 24-48 
h of administration and remained colonized for the duration of the experiment. As expected, 
E. coli A192PP produced lethal infection in all colonized pups (Fig. 3) and although a 
proportion of pups colonized with A192PPΔclbA::kan (Figure 3A) and A192PPΔclbP::kan 
(Fig. 3B) did not survive, the overall lethal effect as a result of these mutations was 
significantly attenuated. Thus, disruption of clbA increased survival by 50% and of clbP by 
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30%. Introduction of an intact clbA gene restored the lethal effect whilst enhanced lethality 
over E. coli A192PP was found when the clbP gene was complemented using plasmid 
pBRSK.clbP. 
Colibactin influences colonization of, and induces genotoxic effects in, the neonatal 
GI tract  
Current evidence suggests that the likely site of translocation of E. coli K1 from GI lumen to 
the blood compartment is the small intestine (21), with the proximal and mid-section of this 
region as the most likely loci of colonization preceding systemic invasion. At both sites, 
inactivation of clbA and clbP in E. coli A192PP resulted in a significantly lower population of 
colonizing bacteria (Fig. 4). With A192PPΔclbA::kan and A192PPΔclbP::kan, significantly 
fewer viable bacteria were recovered from the blood compared to the parent strain and fewer 
bacteria were recovered from the major organs of bacterial clearance but, with the exception 
of the spleen, following infection with the clbP mutant these did not reach levels of statistical 
significance (Fig. 4). We also examined the possibility that GI-colonizing E. coli A192PP 
engendered ds DNA breaks in enterocytes lining the mid-SI. We therefore obtained mid-SI 
sections from P2 pups 48 h and 72 h after oral administration of E. coli A192PP strains and 
assessed DNA damage by monitoring phosphorylation of histone γ-H2AX , a sensitive 
marker of ds DNA breaks (33), with monoclonal rabbit anti-γ-H2AX antibody. There was 
evidence of extensive ds DNA breaks in cells lining the mid-SI lumen from pups exposed to 
A192PP, but not to A192PPΔclbA::kan and A192PPΔclbP::kan mutants or the negative 
control (Fig. 5A). At 48 h and 72 h after colonization, dsDNA breaks were found in, 
respectively, 35.7% and 33.6% of cells lining the mid-SI lumen of pups exposed to E. coli 
A192PP, significantly more than in the cells from pups exposed to A192PPΔclbA::kan and 
A192PPΔclbP::kan mutants (P<0.01 and P<0.001 at 48 and 72 hours respectively; ANOVA) 
(Fig. 5B). 
DISCUSSION 
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The blood isolate E. coli A192 efficiently (100%) colonized the GI tract of neonatal rats but 
elicited bacteremia in only 25-35% of colonized animals (18, 32), whereas the passaged 
derivative A192PP caused invasive disease in essentially all pups colonized at P2 (23, 32). 
GI tract colonization of P2 pups by E. coli A192PP was accompanied by extensive 
replication of A192PP to yield steady-state populations of 107-108/g within 24 h (21). A 
similar degree of clonal expansion was noted at 24 h in this study, particularly in the proximal 
and mid-SI; inactivation of both clbA and clbP gave rise to a statistically significant, five- to 
tenfold reduction in the size of the colonizing population in these regions of the GI tract (Fig. 
4). It is likely that the capacity of potential neuropathogens to colonise the neonate in 
numbers sufficient to permit their translocation to the blood compartment during the first few 
days of life represents a key determinant of outcome, although very little experimental or 
epidemiological data is available to assess the relative importance of quantitative aspects of 
early gastrointestinal colonisation in either naturally occurring or experimental infections. 
However, these reductions in colonization are concomitant with a reduced capacity to cause 
bacteremia and death (Fig. 3). In this context, it is known that colonization with A192PP 
induces massive down-regulation of tff2 encoding Trefoil factor 2, a compact protein involved 
in assembly and maturation of the mucin layer that keeps luminal bacteria away from the 
enterocyte surface (21, 33). 
Colibactin production has a substantial impact on the capacity of A192PP to cause lethal 
infection (Fig. 3) following invasion of the blood compartment (Fig. 4), providing a practical 
demonstration that the pks island is associated with bacteremia (6, 9, 12). In line with 
previous observations (5, 7), we found that pks carriage elicits ds DNA breaks in cultured 
cells. DNA ds cleavage is also manifest in gut epithelial cells (Fig. 5) during the period (48-
72 h) of translocation from GI lumen to the blood compartment (21). The blood bioburden of 
E. coli A192PPΔclbA::kan was significantly lower than that achieved by A192PPΔclbP::kan 
24 h after colonization (Fig. 4). ClbA impacts on colibactin and siderophore synthesis, whilst 
ClbP is involved only in colibactin synthesis (12), suggesting that low-molecular-weight iron 
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chelators may also play a significant role in the invasive potential of E. coli K1 infection in the 
neonatal rat. We have previously shown that mutation of clbA impacts siderophore 
biosynthesis when the entD gene (present in E. coli A192PP) is inactivated (12), 
emphasizing that the clbA mutation has the potential to engender pleiotropic effects on 
siderophore and colibactin biosynthesis, even in the presence of a functional entD gene. We 
therefore hypothesize that A192PPΔclbA::kan, compromised with regard to colibactin 
biosynthesis, also displays altered siderophore production, which could contribute to the 
decreased virulence of the clbA mutant compared to the clbP mutant. It should be borne in 
mind, however, that siderphore production in vitro does not inform on the levels of synthesis 
of the chelator during colonization and invasion of infected animals. 
 
Colibactin requires cell-bacterium contact in order to elicit genotoxic effects (5).  We have 
recently obtained as-yet unpublished histological and immunohistochemical evidence that 
A192PP comes into close proximity to enterocytes lining the GI tract, adopts a transcellular 
route across the epithelial barrier and gains access to the circulation via the mesenteric 
lymphatic system. The observations reported here provide additional evidence for this mode 
of translocation, as it is likely that DNA strand breakage occurs predominantly either during 
close-proximity colonisation with, or after internalization of, pks-carrying bacteria.  Colibactin-
mediated DNA damage leads to activation of DNA damage repair pathways that will promote 
the accumulation of mutations with long-term health consequences for the host if exposure 
to the genotoxin persists (7). More transient exposure leads to anaphase bridges, 
chromosomal abnormalities and senescence in dividing cells (7, 34). Recently, it has been 
demonstrated, using a mother-to-offspring transmission model, that colibactin-producing E. 
coli strains impair intestinal permeability to low-molecular-weight molecules and impact oral 
tolerance (35).  We will determine if A192PP colonization impacts on the permeability of the 
gut to micromolecules, macromolecules and particulates in order to reconcile transient or 
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long-term DNA damage with an enhanced capacity to translocate across the gut epithelium. 
Additional processes associated with colibactin production remain to be established. 
In summary, this is the first report to show that colibactin production contributes to the 
capacity of E. coli to cause systemic lethal infections in experimental models that follow that 
natural pathway to infection. Moreover, our findings indicate that the pks island is widely 
distributed amongst neonatal E. coli K1 isolates, suggesting that this virulence factor has an 
important role to play in invasive disease in susceptible neonates. Additional processes 
associated with colibactin production remain to be established. 
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Figure Legends 
FIG 1 Production of colibactin by E. coli A192PP and derivatives determined by methylene 
blue staining (OD660) of HeLa cells exposed to the bacteria indicated; MOI, multiplicity of 
infection, compared to non-exposed control (C).   
FIG 2 Colibactin production by E. coli A192PP induces genotoxic effects. (A), Growth of E. 
coli strains A192PP, A192PPΔclbA::kan and A192PPΔclbP::kan in MH broth at 37°C (200 
orbits min);  ±1 SD, n=3. (B), Production of colibactin by E. coli A192PP and derivatives 
determined by methylene blue staining (OD600) of HeLa cells exposed to the bacteria 
indicated; MOI, multiplicity of infection, compared to non-exposed control.  (C), 
Quantification of double-strand (ds) DNA breaks induced by E. coli A192PP and derivatives; 
A192PPΔclbA::kan+pASK75.clbA and A192PPΔclbP::kan+pBRSK.clbP are complemented 
derivatives of A192PP∆clbA::kan and A192PP∆clbP::kan respectively. HeLa cells were 
incubated with the concentrations of bacteria indicated and ds breaks quantified by 
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determination of γ-H2AX. Z-test was used to determine significant differences of means and 
standard errors between A192PP and A192PPΔclbA, A192PP and 
A192PPΔclbA+pASK75.clbA, A192PPΔclbA and A192PPΔclbA+pASK75.clbA, A192PP and 
A192PPΔclbP, A192PPΔclbP and A192PPΔclbA+pBRSK.clbP, and 
A192PPΔclbA+pASK75.clbA and A192PPΔclbA+pBRSK.clbP (all P<0.001). There were no 
significant differences between A192PPΔclbA and A192PPΔclbP, and A192PP and 
A192PPΔclbP+pBRSK.clbP. 
FIG 3 Colibactin genes are required for expression of full virulence in the rat model of 
neonatal systemic infection. Survival of P2 rats colonized with E. coli K1 A192PP and (A) 
A192PP∆clbA or (B) A192PP∆clbP. GI tract colonization was established by manual feeding 
of 2-6 X 106 CFU. For A, A192PP n=24, A192PP∆clbA::kan n=24, 
A192PP∆clbA::kan+pASK75 n=12, A192PP∆clbA::kan +pASK75.clbA n=12; for B, A192PP 
n=36, A192PP∆clbP::kan n=36, A192PP∆clbP::kan+pBRSK n=12, 
A192PP∆clbP::kan+pBRSK.clbP n=12; log-rank (Mantel-Cox) test: ns, non-significant, 
*P<0.05, **P<0.01. 
FIG 4 Colibactin genes influence the degree of GI tract colonization and blood and organ 
dissemination of E. coli A192PP in the susceptible P2 neonatal rat. Tissues were removed 
24 h after colonization and CFU/g of tissue determined by plating on MacConkey agar: E. 
coli A192PP colonies were detected using K1-specific bacteriophage; mutants were selected 
on medium containing 50µg/ml kanamycin. SI, small intestine. For (A), A192PP n=18, 
A192PP∆clbP::kan (n=18); for (B), A192PP n=17, A192PP∆clbP::kan (n=17); Student’s t 
test: ns, non-significant, *P<0.05, **P<0.01,  ***P<0.001.  
FIG 5 E. coli A192PP induces double-strand (ds) DNA breaks in epithelial cells of the mid-SI. 
P2 rats were colonized with E. coli A192PP, A192PP∆clbA::kan or A192PP∆clbP::kan  by 
feeding from an Eppendorf pipette; controls (uninfected group) were fed MH broth. Animals 
were sacrificed at 48 h (n=6) or 72 h (n=6) after administration of the colonizing bacteria or 
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broth. Sections of the mid-SI were embedded in paraffin and stained for γH2AX (brown), a 
biomarker for breaks in ds DNA, and counterstained with haematoxylin. (A), Representative 
mid-SI sections. Scale bar 100 µm. (B), Quantification of ds DNA breaks in mid-SI sections. 
Groups of 6 rats were analyzed, mean ± SD; one-way ANOVA with Tukey’s multiple 
comparison test, *P<0.05, **P<0.01,  ***P<0.001.   
 
 
 
Table 1. Strains and plasmids used in this study 
Strains Genotype or phenotype Source 
A192PP 018:K1:H7; virulent in rat model of neonatal meningitis [23] 
A192PPΔclbA::kan clbA mutant of A192PP; KanR This study 
A192PPΔclbA::kan + 
pASK75 
clbA mutant of A192PP carrying pASK75 clbA+; KanR, AmpR This study 
A192PPΔclbA::kan + 
pASK75.clbA 
clbA mutant of A192PP carrying pASK75; KanR, AmpR This study 
A192PPΔclbP::kan clbP mutant of A192PP; KanR This study 
A192PPΔclbP::kan + 
pBRSK 
clbP mutant of A192PP carrying pBRSK; KanR, AmpR This study 
A192PPΔclbP::kan + 
pBRSK.clbP 
clbP mutant of A192PP carrying pBRSK clbP+; KanR, AmpR This study 
   
Plasmids   
pASK75.clbA Plasmid carrying clbA gene; Ampr [25] 
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pBRSK.clbP Plasmid carrying clbP gene This study 
 
